DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival
Open Access
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 84 (3) , 217-223
- https://doi.org/10.1016/s0954-6111(08)80038-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survivalBritish Journal of Cancer, 1989
- PLOIDY AS A PROGNOSTIC DETERMINANT IN SURGICALLY TREATED LUNG CANCERThe Lancet, 1987
- Prognostic significance of flow cytometry in lung cancer. A 5-year studyCancer, 1987
- Flow DNA analysis in human lung cancer: potentiality and limitations due to sampling methodsBiology of the Cell, 1986
- Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinomaCancer, 1985
- Application of DNA flow cytometry to paraffin‐embedded archival material for the study of aneuploidy and its clinical significanceCytometry, 1985
- Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin‐embedded tissueCytometry, 1985
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Non-small-cell lung carcinoma: Tumor characterization on the basis of flow cytometrically determined cellular heterogeneityCytometry, 1983
- Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample‐storage, staining and internal standardizationCytometry, 1983